Samsung Biologics เลือกแพลตฟอร์ม Growth Direct® ของ Rapid Micro Biosystems เพื่อทำการทดสอบการควบคุมคุณภาพทางจุลชีววิทยาที่สำคัญโดยอัตโนมัติ
04 janv. 2024 09h18 HE
|
Rapid Micro Biosystems, Inc.
โลเวลล์ แมสซาชูเซตส์ , Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“บริษัท”)...
Samsung Biologics memilih platform Growth Direct® oleh Rapid Micro Biosystems untuk mengautomasikan ujian kawalan kualiti mikrobiologi kritikal
04 janv. 2024 09h18 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) ("Syarikat"), sebuah syarikat teknologi sains hayat inovatif yang menyediakan penyelesaian automasi...
Samsung Biologics, 주요 미생물 품질 관리 테스트 공정 자동화를 위해 Rapid Micro Biosystems의 Growth Direct® 플랫폼 채택
04 janv. 2024 09h18 HE
|
Rapid Micro Biosystems, Inc.
매사추세츠주 로웰, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- 회사가 핵심과제로 삼은 자동화 솔루션을 통해 헬스케어 제품의 효율적인 제조와 신속하고 안전한 출시를 지원하는 혁신적인 생명과학 기술 기업인 Rapid Micro Biosystems, Inc. (래피드 마이크로 바이오시스템즈) (나스닥: RPID) (이하...
Samsung Biologics memilih platform Growth Direct® milik Rapid Micro Biosystems untuk mengotomatiskan pengujian kendali mutu mikrobiologi yang penting
04 janv. 2024 09h18 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Perusahaan”), perusahaan teknologi ilmu hayati inovatif yang menyediakan solusi otomatisasi yang...
Samsung Biologics 選擇 Rapid Micro Biosystems 的 Growth Direct® 平台以自動化關鍵微生物品質控制測試
04 janv. 2024 09h18 HE
|
Rapid Micro Biosystems, Inc.
羅威爾，麻薩諸塞州, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID)（以下簡稱「公司」）是一間創新生命科學技術公司，提供關鍵任務自動化解決方案，以促進醫療保健產品的高效生產和快速、安全發布。該公司今日宣布 Samsung Biologics (KRX: 207940.KS) 選擇了...
Samsung Biologics 选择 Rapid Micro Biosystems 的 Growth Direct® 平台自动化关键微生物质量控制测试
04 janv. 2024 09h18 HE
|
Rapid Micro Biosystems, Inc.
洛厄尔，马萨诸塞州, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID)（简称“公司”），一家提供任务关键自动化解决方案以加快医疗保健产品高效生产和快速、安全发布的创新生命科学技术公司，今天宣布 Samsung Biologics (KRX: 207940.KS) 已选择 Growth...
Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing
04 janv. 2024 07h00 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference
03 janv. 2024 07h15 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
07 nov. 2023 16h15 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results
03 nov. 2023 07h00 HE
|
Rapid Micro Biosystems, Inc.
Reports third quarter 2023 total revenue of $6.1 million, representing growth of 30% compared to third quarter 2022 Reaffirms full year 2023 total revenue guidance of at least $22.0 million,...